Abstract
Ethambutol (EMB) is one of the first-line drugs in the treatment of tuberculosis. EMB induced ocular toxicity is a rare side-effect that observed as either dose or duration related effect and reversible on therapy discontinuation. We report a rare case of EMB-induced optic neuritis, even though the dose and duration are not related to it. After withdrawal of the drug, we observed there is a recovery and mapping of the central visual field showed only slight enlargement of the blind spot in the right eye. If there is no vision improvement, but ocular toxicity is not severe, isoniazid should also be stopped.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Basic & Clinical Pharmacology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.